Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Blocklisting application

27 Oct 2021 08:52

RNS Number : 4162Q
Thruvision Group PLC
27 October 2021
 

 

27 October 2021

Thruvision Group plc

 

("Thruvision" or the "Company")

 

Blocklisting application

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, announces that an application has been made to the London Stock Exchange for the blocklisting of 1,281,600 ordinary shares of 1p each ("New Ordinary Shares").

 

The New Ordinary Shares will be issued from time to time pursuant to the exercise of employee share options under the Thruvision Group plc Sharesave Scheme.

 

On exercise, these shares will be issued credited as fully paid and will rank pari passu with the existing ordinary shares in issue. It is expected that admission will be granted on 1 November 2021.

 

 

For further information please contact:

 

Thruvision Group plc

Colin Evans, Chief Executive

Tom Black, Executive Chairman

+44 (0)1235 425 400

Investec Bank plc

Patrick Robb / James Rudd / Sebastian Lawrence

+44 (0)20 7597 5970

FTI Consulting LLP

Matt Dixon / Tom Blundell

+44 (0)20 3727 1000

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford, and Washington DC.

www.thruvision.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSDDLBLFBLEFBF
Date   Source Headline
31st Aug 20109:34 amRNSHolding(s) in Company
23rd Aug 20107:00 amRNSOffer Update
30th Jul 20105:22 pmRNSPosting of Offer Document
30th Jul 20107:00 amRNSRecommended Cash Offer
23rd Jul 20107:00 amRNSAcquisition
30th Jun 20109:10 amRNSBoard Changes
16th Apr 201011:10 amRNSHolding(s) in Company
13th Apr 20102:00 pmRNSManagement Appointments
9th Apr 20109:31 amRNSHolding(s) in Company
25th Mar 20107:00 amRNSAcquisition
16th Mar 20103:15 pmRNSHolding(s) in Company
9th Mar 20105:27 pmRNSHolding(s) in Company
9th Mar 20105:19 pmRNSHolding(s) in Company
9th Mar 20103:34 pmRNSHolding(s) in Company
9th Mar 20101:16 pmRNSHolding(s) in Company
5th Mar 20105:44 pmRNSHolding(s) in Company
5th Mar 20103:08 pmRNSHolding(s) in Company
5th Mar 20103:02 pmRNSHolding(s) in Company
4th Mar 20103:47 pmRNSHolding(s) in Company
4th Mar 20108:01 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.